See thru equity just upgraded INNV price target to $1.5 but is not the only one who thinks INNV is worth more than a dollar, CNN Money has a $1.36 price target for INNV as well after their deal with CVS to do a pilot with their men's fertility drug Androferti, and the possible commercialization of other pruducts like Fluticare (allergies) Zestra(woman pleasure) Prostagorx (prostate health) Vessele, etc...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.